0001667011-25-000029
SEC filingArteris holds $53.9M cash & investments against zero debt, with RPO of $95.8M and vendor financing commitments of $2.5M.
As of June 30, 2025, Arteris reported cash and cash equivalents of $16.1 million and short-term investments of $21.9 million, together $38.0 million. Long-term investments added $15.9 million, bringing total liquidity to $53.9 million. The company has no long-term debt; the only debt-like obligations are vendor financing arrangements of $2.5 million (present value). Stockholders' deficit stood at ($7.5 million), driven by an accumulated deficit of $154.1 million and additional paid-in capital of $146.4 million. The current ratio (current assets $61.5M / current liabilities $62.6M) was 0.98x. Operating lease liabilities were $4.8 million, with right-of-use assets of $4.4 million.
The company disclosed $95.8 million in remaining performance obligations (RPO) as of June 30, 2025, of which $48.2 million is expected to be recognized within 12 months. Deferred revenue totaled $81.9 million. Vendor financing arrangements carry undiscounted cash flows of $2.7 million (present value $2.5M), with $1.3 million due in the remainder of 2025 and $1.3 million in 2026-2027. Operating lease obligations have undiscounted cash flows of $5.9 million, with $0.7 million in 2025, $1.6 million in 2026, and the remainder through 2034. The company also maintains a $0.4 million letter of credit for its headquarters facility. No material non-cancelable purchase commitments were disclosed beyond these.
Arteris does not have a share buyback program or pay dividends. Capital expenditures for the first half of 2025 were $0.5 million (1.6% of revenue). The company made $0.6 million in principal payments on vendor financing arrangements. There was no new debt issuance; total vendor financing increased slightly from $2.1 million at year-end 2024 to $2.5 million. Stock-based compensation was $8.8 million, and proceeds from stock option exercises and ESPP totaled $2.0 million, providing modest equity inflows.
The company operates as a single reportable segment. Disaggregated revenue by product group shows Licensing, support & maintenance of $30.4 million (92% of total), Variable royalties of $2.6 million (8%), and Other of $0.04 million for the six months ended June 30, 2025. The revenue growth of 20% YoY was driven primarily by new license agreements with existing customers and new customer additions. The notes did not provide a geographic breakdown of revenue at the segment level, though management's discussion noted 60% of revenue from outside the United States and 25% from China.
Despite a net loss of $17.3M, operating cash flow remained positive at $0.4M, driven by non-cash charges (stock-based comp $8.8M, depreciation $1.7M) and a significant increase in deferred revenue ($6.3M) reflecting billings ahead of revenue recognition. Accounts receivable decreased $1.9M, providing a tailwind. However, prepaid expenses increased $2.3M, partially offsetting. Capital expenditures rose to $0.5M, representing a higher capex intensity relative to operating cash flow (1.4x). As a result, free cash flow (CFO less capex) was -$0.2M. Financing activities generated $1.5M from stock option exercises and employee stock purchase plan, sufficient to cover the negative free cash flow and support the cash balance increase. No share repurchases or dividends were paid. Overall, cash flow from operations is structurally weak but supported by deferrals and non-cash items; investing demands are modest but exceed internally generated cash.